Zinc(II) Complexes of Acylpyrazolones Decorated with a Cyclohexyl Group Display Antiproliferative Activity Against Human Breast Cancer Cells

[1]  Yu-hua Fan,et al.  Crystal structures and anticancer activities of five novel pyrazolone-enamine transition metal complexes with 4-benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one , 2018, Journal of Molecular Structure.

[2]  R. Scopelliti,et al.  Synthesis, characterization and cytotoxicity of arene-ruthenium(ii) complexes with acylpyrazolones functionalized with aromatic groups in the acyl moiety. , 2018, Dalton transactions.

[3]  Ž. Bugarčić,et al.  Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. , 2017, European journal of medicinal chemistry.

[4]  M. Dušek,et al.  A detailed study on the interaction of a novel water-soluble glycine bridged zinc(II) Schiff base coordination polymer with BSA: Synthesis, crystal structure, molecular docking and cytotoxicity effect against A549, Jurkat and Raji cell lines , 2017 .

[5]  N. Revathi,et al.  Biologically Active Cu(II), Co(II), Ni(II) and Zn(II) Complexes of Pyrimidine Derivative Schiff Base: DNA Binding, Antioxidant, Antibacterial and In Vitro Anticancer Studies , 2017, Journal of Fluorescence.

[6]  E. Drioli,et al.  Microtube array membrane bioreactor promotes neuronal differentiation and orientation , 2017, Biofabrication.

[7]  N. Raman,et al.  Role of Knoevenagel condensate pyrazolone derivative Schiff base ligated transition metal complexes in biological assay and cytotoxic efficacy , 2017 .

[8]  R. Ortega,et al.  Zinc and Copper Effects on Stability of Tubulin and Actin Networks in Dendrites and Spines of Hippocampal Neurons. , 2017, ACS chemical neuroscience.

[9]  E. Drioli,et al.  Neuronal membrane bioreactor as a tool for testing crocin neuroprotective effect in Alzheimer’s disease , 2016 .

[10]  R. Scopelliti,et al.  Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety. , 2016, Inorganic chemistry.

[11]  Agnieszka Gornowicz,et al.  Biological evaluation of dimethylpyridine–platinum complexes with potent antiproliferative activity , 2016, Journal of enzyme inhibition and medicinal chemistry.

[12]  A. Linden,et al.  Organotin(IV) complexes derived from proteinogenic amino acid: synthesis, structure and evaluation of larvicidal efficacy onAnopheles stephensimosquito larvae , 2016, Applied Organometallic Chemistry.

[13]  R. Subramaniam,et al.  New anticancer zinc(II) complexes comprising thiosemicarbazones of saturated ring: structure, DNA/protein binding, DNA cleavage, topoisomerase‐1 inhibition and anti‐proliferation studies , 2016 .

[14]  S. Tabassum,et al.  Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action , 2016 .

[15]  R. Alizadeh-Navaei,et al.  Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line , 2016, Cancer Cell International.

[16]  You-nian Liu,et al.  Cytotoxicity, DNA binding and cell apoptosis induction of a zinc(II) complex of HBrQ , 2015 .

[17]  C. Pettinari,et al.  Recent advances in acylpyrazolone metal complexes and their potential applications , 2015 .

[18]  D. Maria,et al.  Synthesis, characterization and biological evaluation of Rutin-zinc(II) flavonoid -metal complex. , 2015, Chemico-biological interactions.

[19]  C. Pettinari,et al.  Dinuclear (η6-arene) ruthenium(II) acylpyrazolone complexes: Synthesis, characterization and cytotoxicity , 2015 .

[20]  A. Garufi,et al.  Zn(II)-curc targets p53 in thyroid cancer cells , 2015, International journal of oncology.

[21]  J. Holopainen,et al.  Osteogenic and osteoclastogenic differentiation of co-cultured cells in polylactic acid-nanohydroxyapatite fiber scaffolds. , 2015, Journal of biotechnology.

[22]  A. Crispini,et al.  Zn(ii) and Cu(ii) complexes containing bioactive O,O-chelated ligands: Homoleptic and heteroleptic metal-based biomolecules. , 2015, Dalton transactions.

[23]  E. Drioli,et al.  Neuronal growth and differentiation on biodegradable membranes , 2015, Journal of tissue engineering and regenerative medicine.

[24]  M. Mozzicafreddo,et al.  Arene-ruthenium(II) acylpyrazolonato complexes: apoptosis-promoting effects on human cancer cells. , 2014, Journal of medicinal chemistry.

[25]  A. Garufi,et al.  Degradation of mutant p53H175 protein by Zn(II) through autophagy , 2014, Cell Death and Disease.

[26]  L. Ricci-Vitiani,et al.  Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo , 2014, Cell Death and Disease.

[27]  S. Manna,et al.  Synthesis and characterization of some water soluble Zn(II) complexes with (E)-N-(pyridin-2-ylmethylene)arylamines that regulate tumour cell death by interacting with DNA. , 2014, Dalton transactions.

[28]  R. Jadeja,et al.  Zn(II) coordination compounds derived from 4-acyl pyrazolones and 1,10 phenanthroline: Syntheses, crystal structures, spectral analysis and DNA binding studies , 2013 .

[29]  C. Leonetti,et al.  A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells , 2013, Journal of experimental & clinical cancer research : CR.

[30]  A. Crispini,et al.  Improving the bioactivity of Zn(II)-curcumin based complexes. , 2013, Dalton transactions.

[31]  K. Moelling,et al.  Photodynamic agents with anti-metastatic activities. , 2013, ACS chemical biology.

[32]  A. Crispini,et al.  Non-classical anticancer agents: on the way to water soluble zinc(II) heteroleptic complexes. , 2013, Dalton transactions.

[33]  Wentao Xu,et al.  Zinc protects HepG2 cells against the oxidative damage and DNA damage induced by ochratoxin A. , 2013, Toxicology and applied pharmacology.

[34]  Ping Zhan,et al.  XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis , 2013, Journal of experimental & clinical cancer research : CR.

[35]  Mohd Afzal,et al.  Synthesis and characterization of copper(II) and zinc(II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and antimicrobial activity. , 2012, European journal of medicinal chemistry.

[36]  Elisabeta I. Szerb,et al.  “Green light” for Zn(II) mesogens , 2012 .

[37]  J. Muthumary,et al.  A series of oxyimine-based macrocyclic dinuclear zinc(II) complexes enhances phosphate ester hydrolysis, DNA binding, DNA hydrolysis, and lactate dehydrogenase inhibition and induces apoptosis. , 2012, Inorganic chemistry.

[38]  I. D'Agnano,et al.  DNA binding and cytotoxicity of fluorescent curcumin-based Zn(II) complexes , 2012 .

[39]  E. Alessio.  Bioinorganic Medicinal Chemistry: ALESSIO:BIO. INORG. CHEM. O-BK , 2011 .

[40]  J. Ellman,et al.  Design and synthesis of nonpeptidic, small molecule inhibitors for the Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. , 2010, Organic & biomolecular chemistry.

[41]  S. Tabassum,et al.  Synthesis, structural and spectroscopic characterization and biomimetic properties of new copper, manganese, zinc complexes: identification of possible superoxide-dismutase mimics bearing hydroxyl radical generating/scavenging abilities. , 2010, Journal of inorganic biochemistry.

[42]  A. Valentini,et al.  Non-classical anticancer agents: synthesis and biological evaluation of zinc(II) heteroleptic complexes. , 2010, Dalton transactions.

[43]  T. Stanojković,et al.  Zinc(II) complexes of 2-acetyl pyridine 1-(4-fluorophenyl)-piperazinyl thiosemicarbazone: Synthesis, spectroscopic study and crystal structures - potential anticancer drugs. , 2010, Journal of inorganic biochemistry.

[44]  B. Keppler,et al.  Comparative Solution Equilibrium Study of the Interactions of Copper(II), Iron(II) and Zinc(II) with Triapine (3‐Aminopyridine‐2‐carbaldehyde Thiosemicarbazone) and Related Ligands , 2010 .

[45]  B. Ghosh,et al.  Inhibitory effect of beta-diketones and their metal complexes on TNF-alpha induced expression of ICAM-1 on human endothelial cells. , 2009, Bioorganic & medicinal chemistry.

[46]  R. Jastrząb,et al.  Self-assembled synthesis, characterization and antimicrobial activity of zinc(II) salicylaldimine complexes , 2009 .

[47]  Hiromu Sakurai,et al.  Current state for the development of metallopharmaceutics and anti-diabetic metal complexes. , 2008, Chemical Society reviews.

[48]  M. Hiromura,et al.  Molecular mechanism of antidiabetic zinc–allixin complexes: regulations of glucose utilization and lipid metabolism , 2008, JBIC Journal of Biological Inorganic Chemistry.

[49]  C. Pettinari,et al.  Synthesis, Molecular Structure (X-ray and DFT), and Solution Behavior of Titanium 4-Acyl-5-pyrazolonates. Correlations with Related Antitumor β-Diketonato Derivatives , 2007 .

[50]  T. Alber,et al.  Fragment-based substrate activity screening method for the identification of potent inhibitors of the Mycobacterium tuberculosis phosphatase PtpB. , 2007, Journal of the American Chemical Society.

[51]  Z. Chohan,et al.  Metal‐based antibacterial and antifungal amino acid derived Schiff bases: their synthesis, characterization and in vitro biological activity , 2007 .

[52]  O. Issinger,et al.  Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. , 2006, International journal of oncology.

[53]  Xiaolian Zhang,et al.  Zinc(II) and copper(II) complexes of beta-substituted hydroxylporphyrins as tumor photosensitizers. , 2006, Bioorganic & medicinal chemistry letters.

[54]  C. Pettinari,et al.  Acylpyrazolone ligands : Synthesis, structures, metal coordination chemistry and applications , 2005 .

[55]  A. Gindulyte,et al.  (4‐Acyl‐5‐pyrazolonato)titanium Derivatives: Oligomerization, Hydrolysis, Voltammetry, and DFT Study , 2003 .

[56]  S. Diez,et al.  Synthesis, structure, and antitumor activity of a novel tetranuclear titanium complex. , 2000, Journal of medicinal chemistry.

[57]  C. Pettinari,et al.  On the interaction of acylpyrazolonates with zinc(II) acceptors: the role of ancillary ligands , 2000 .

[58]  R. Macdonald.  The role of zinc in growth and cell proliferation. , 2000, The Journal of nutrition.

[59]  U. Schilde,et al.  Aquabis(3-methyl-4-octanoyl-1-phenyl-5-pyrazolonato-O,O')zinc(II) and Bis(ethanol-O)bis(3-methyl-1-phenyl-4-stearoyl-5-pyrazolonato-O,O')cadmium(II) , 1998 .

[60]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[61]  S. M. Taghdisi,et al.  Kojic acid and its manganese and zinc complexes as potential radioprotective agents. , 2007, Bioorganic & medicinal chemistry letters.

[62]  N. Zaffaroni,et al.  Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), diffraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines. , 2006, Journal of inorganic biochemistry.